After the marketization reform of drug prices will fall? 
 
 
The 2015-05-06 18:14:21 | source: China youth daily 

    The national development and reform commission jointly with the national health and family planning commission, the ministry of human resources and social security departments jointly issued the notice about the opinions of printed and distributed to promote the reform of drug prices (hereinafter referred to as "notice"), from June 1, 2015 to cancel most of the drugs government pricing, improve the mechanism of drug purchase, give play to the role of health charged fees, drug actual transaction prices are mainly formed by the market competition. (Beijing, May 5) 
 
    By hot half year more price marketization reform, its final plan finally showed up. Look from the "notice", in addition to narcotic drugs and the psychotropic drugs of category I, the other drugs were cancelled the government pricing, formed by the market price through different ways, such as medical insurance fund pays medicines, by making medicare payment standard lead drug prices reasonable; Patented drugs through the transparent, participating in the negotiation mechanism formation price... 
 
    The public concerned about most, in fact, or after the marketization reform of drug prices will rise? In charge of the national development and reform commission said that the vast majority of drug market transaction price will not rise. But the end of drug prices, remains to be seen. Obviously, the majority of people on drug prices market-oriented reform and a positive attitude, because the government pricing is easy to cause price distortions, medical resource configuration in the future by the market is more advantageous to form a reasonable price. 
 
    Despite the anticipated price marketization reform, reform the success, the key lies in supporting reform can reach the designated position. Cancel the government pricing is only the first step, how to go after a few steps are more important. For example, how to perfect the mechanism of drug purchase, it relates to the success or failure of the reform. At present, the "notice" for perfecting the mechanism of drug purchase description is too simple, only drug procurement system, mechanism system reform, to promote the drug prices return to reasonable. 
 
    Drug centralized bid procurement system for many years, "expensive" is still not solved, the personage inside course of study often targeted drug bidding procurement system. At the same time, also have the personage inside course of study points out that the procurement system has a problem, namely the tendering agency, neither buyer nor payment, violates the "medical institutions is the main part of the bidding procurement" principle. 
 
    In my opinion, the existing system of drug purchase, mechanisms should be to build, both to the industry's opinions, also want to refer to public opinion, for example, since adhere to the centralized purchasing, secondary bargaining should be allowed to hospital. How to give play to the role of health control fee, also related to the reform success or failure, must pay mode and reform the existing health care system. 
 
    "Notice" to the "health charged fees" expression is relatively simple, also need special reform. Some parts from the current pilot "health charged fees", is based on the bidding price control. If the bidding price is not reasonable, health care is difficult to control nature. The author suggested that health care should be a separate fee mechanism, independent operation, can't rely on the bidding prices, the need to develop health care departments approved independent ability of medical expenses, etc. 
 
    Price marketization reform is also inseparable from the reform of public hospitals, only cancel the drug for medical, keep the doctor away from drugs, the interests of disputes drug prices return to reasonable to just have hope. But so far, cancel "medicine for the medical" has not been rolled out. 
 
    In addition, new drug approval system also needs reform. Prices are down hard, has a lot to do with this. It is understood that the current QiBaQian kind of drug, but batch number out ShiBaJiuWanGe medicine; A kind of medicine has dozens of, the same drug prices vary more than a dozen times. If no new drug approval system reform, change a "ma3 jia3" get medicine, a lot of old medicine after sales will be a high price. In addition, corruption phenomenon existing in the new drug approval, also need to remove.